Thorlef Spickschen, Director at Clovis Oncology, Inc. (CLVS), sold 9,000 shares at $56.38 ($505K) on 2013-12-04, disclosed to the SEC on 2013-12-06.
Open-market sale of $505k CLVS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.38 | 3,000 | $169K | 33.5% |
| 2 | $55.96 | 6,000 | $336K | 66.5% |
| Total | $56.10 avg | 9,000 | $505K | 100% |
| Filing → |
| CLVS | SELL | 2018-04-09 | $270K | — | Filing → |
| CLVS | SELL | 2018-03-09 | $277K | — | Filing → |
| CLVS | SELL | 2018-02-23 | $270K | — | Filing → |